IT1256320B - Derivati eterociclici - Google Patents

Derivati eterociclici

Info

Publication number
IT1256320B
IT1256320B ITMI922661A ITMI922661A IT1256320B IT 1256320 B IT1256320 B IT 1256320B IT MI922661 A ITMI922661 A IT MI922661A IT MI922661 A ITMI922661 A IT MI922661A IT 1256320 B IT1256320 B IT 1256320B
Authority
IT
Italy
Prior art keywords
compounds
relates
heterocyclic derivatives
new compounds
treatment
Prior art date
Application number
ITMI922661A
Other languages
English (en)
Italian (it)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of ITMI922661A0 publication Critical patent/ITMI922661A0/it
Publication of ITMI922661A1 publication Critical patent/ITMI922661A1/it
Application granted granted Critical
Publication of IT1256320B publication Critical patent/IT1256320B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ITMI922661A 1991-12-04 1992-11-20 Derivati eterociclici IT1256320B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919125842A GB9125842D0 (en) 1991-12-04 1991-12-04 Heterocyclic derivatives

Publications (3)

Publication Number Publication Date
ITMI922661A0 ITMI922661A0 (it) 1992-11-20
ITMI922661A1 ITMI922661A1 (it) 1993-06-05
IT1256320B true IT1256320B (it) 1995-11-30

Family

ID=10705730

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI922661A IT1256320B (it) 1991-12-04 1992-11-20 Derivati eterociclici

Country Status (10)

Country Link
JP (1) JPH05255327A (pt)
BE (1) BE1005473A3 (pt)
CA (1) CA2082668A1 (pt)
DE (1) DE4239440A1 (pt)
FR (1) FR2684672A1 (pt)
GB (2) GB9125842D0 (pt)
IE (1) IE922785A1 (pt)
IT (1) IT1256320B (pt)
NL (1) NL9202091A (pt)
ZA (1) ZA928742B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5439911A (en) * 1992-12-28 1995-08-08 Shionogi & Co., Ltd. Aminopyrimidine derivatives and their production and use
ES2126061T3 (es) * 1993-03-24 1999-03-16 American Home Prod Piridopirimidinas substituidas como antihipertensores.
KR100300566B1 (ko) * 1994-09-17 2001-11-22 조생현 피리미디논유도체와그의제조방법및용도
US6440965B1 (en) * 1997-10-15 2002-08-27 Krenitsky Pharmaceuticals, Inc. Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system
US6583148B1 (en) 1999-04-08 2003-06-24 Krenitsky Pharmaceuticals, Inc. Neurotrophic substituted pyrimidines
EP1303495B1 (en) 2000-07-24 2010-05-26 Krenitsky Pharmaceuticals, Inc. Substituted 5-alkynyl pyrimidines having neurotrophic activity
GB0117396D0 (en) 2001-07-17 2001-09-05 Glaxo Group Ltd Chemical compounds
GB0308208D0 (en) 2003-04-09 2003-05-14 Glaxo Group Ltd Chemical compounds
DE60303238T2 (de) * 2003-04-25 2006-09-14 Actimis Pharmaceuticals, Inc., La Jolla Pyrimidin-Essigsäure Derivate geeignet zur Behandlung von CRTH2-bedingten Krankheiten
PL1718649T3 (pl) 2004-01-31 2009-11-30 Actimis Pharmaceuticals Inc Pochodne kwasu imidazo[1,2-c]pirymidynylooctowego
TW200922587A (en) 2007-09-25 2009-06-01 Actimis Pharmaceuticals Inc Alkylthio pyrimidines as CRTH2 antagonists
MX2010003178A (es) 2007-09-25 2010-04-30 Actimis Pharmaceuticals Inc Primidinas sustituidas con 2-s-bencilo como antagonistas de crth2.
KR102481705B1 (ko) * 2020-08-04 2022-12-27 연세대학교 산학협력단 트리아졸 유도체를 유효성분으로 포함하는 간 섬유증의 예방 또는 치료용 조성물
CN117136189A (zh) * 2021-04-09 2023-11-28 先声再明医药有限公司 泛素特异性蛋白酶1(usp1)抑制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0424317A3 (en) * 1989-10-19 1991-09-25 Ciba-Geigy Ag Pyrimidines
IL99246A0 (en) * 1990-09-10 1992-07-15 Abbott Lab Angiotensin ii receptor antagonists and pharmaceutical compositions containing them
US5149699A (en) * 1991-10-24 1992-09-22 American Home Products Corporation Substituted pyridopyrimidines useful as antgiotensin II antagonists

Also Published As

Publication number Publication date
JPH05255327A (ja) 1993-10-05
ITMI922661A0 (it) 1992-11-20
ZA928742B (en) 1993-06-09
GB9125842D0 (en) 1992-02-05
ITMI922661A1 (it) 1993-06-05
CA2082668A1 (en) 1993-06-05
BE1005473A3 (fr) 1993-08-03
DE4239440A1 (pt) 1993-06-09
GB9225283D0 (en) 1993-01-27
NL9202091A (nl) 1993-07-01
FR2684672A1 (fr) 1993-06-11
IE922785A1 (en) 1993-06-16
GB2262096A (en) 1993-06-09

Similar Documents

Publication Publication Date Title
ATE204873T1 (de) Naphthyridinderivate als angiotensin-ii- antagonist-inhibitoren
NO174202C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktivt azainden-derivater
ATE219764T1 (de) Zimtsäurederivate und deren verwendung als integrin-antagonisten
ATE202337T1 (de) Cyclopropylalkansäurederivate
ATE260255T1 (de) 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate
DE50011582D1 (de) Neuartige dicarbonsäurederivate mit pharmazeutischen eigenschaften
FI810604L (fi) Foerfarande foer framstaellning av indanderivat
ATE205494T1 (de) Pyridylfuran- und pyridylthiphenderivate und deren pharmazeutische verwendung
IT1256320B (it) Derivati eterociclici
FI913478A0 (fi) Diazinderivat.
RU94042907A (ru) Производные имидазопиридина, способ их получения, фармацевтическая композиция и способ ее получения
GB9113628D0 (en) Heterocyclic derivatives
PT992509E (pt) Novos derivados macrolidos
ATE237614T1 (de) Benzo(c)chinolizin derivate,deren herstellung und verwendung als 5-alfa-reduktase inhibitoren
IL78776A (en) (2,4-diphenyl-1,3-dioxan-5-yl)hexenoic acid derivatives,their production and pharmaceutical compositions containing them
DE69330601T2 (de) Serotoninergische ergolin derivate
FI892685A0 (fi) Menetelmä uusien, sytostaattisesti vaikuttavien antrasykliinijohdannaisten valmistamiseksi
ATE222583T1 (de) Derivate substituierter amidinonaphthylester
DE69908855D1 (de) 9a, 11b-dehydro Derivative von 9-oxime-3-keto-6-0-methylerythromycin
JO1697B1 (en) Pyridine derivatives
RU94019332A (ru) 2-замещенные пергидро-1-h-пиридо/1,2-а/пиразины, способ их получения, фармацевтическая композиция и способ лечения
DK214884D0 (da) Chlorphenoxyacetatderivat

Legal Events

Date Code Title Description
0001 Granted